Alliancebernstein L.P. Zynerba Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$3.31 - $6.54 $170,465 - $336,810	-51,500 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.9 - $6.16 $16,820 - $35,728	5,800 Added 12.69%	51,500 $197,000
Q2 2019 Aug 14, 2019	BUY	$5.4 - $15.5 $246,780 - $708,350	45,700 New	45,700 $619,000
Q2 2018 Aug 13, 2018	SELL	$7.98 - $12.39 $168,378 - $261,429	-21,100 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$8.69 - $14.59 $183,359 - $307,849	21,100	21,100 $264,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.